Biotech | August 07, 2021
Sanofi to acquire Translate Bio
Advances deployment of mRNA technology across vaccines and therapeutics development
Advances deployment of mRNA technology across vaccines and therapeutics development
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
Data demonstrate the importance of protecting against serious respiratory infections caused by respiratory syncytial virus, human metapneumovirus and COVID-19
Phase 3 study results will form the basis for future discussions with global regulatory authorities
Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
Accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Subscribe To Our Newsletter & Stay Updated
